New treatment program for adolescents with eating disorders
Official title: The Efficacy, Efficiency, and Patient Experience of a New Intensive Treatment Program for Adolescents With High-complexity Eating Disorders: MINERVA
Run by Fundació Sant Joan de Déu · NCT06431854 · Data updated 2026-11-12
This study is testing a new treatment program for teenagers with serious eating disorders to see if it helps them feel better and recover over about 16 to 20 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 17 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Fundació Sant Joan de Déu Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | October 23, 2023 |
| Main results expected | December 2025 |
| Study ends | December 2026 |
| Registry record updated | May 29, 2024 |
| Trial ID | NCT06431854 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12 to 17 diagnosed with an eating disorder who have not responded well to previous treatments.
✕Probably not a fit
Patients with acute eating disorder pathology or severe biological decompensation may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy, efficiency, and patient experience of a novel treatment program for adolescents suffering from high-complexity eating disorders. The program consists of four phases: inpatient treatment, family treatment apartments, home treatment, and community recovery, spanning approximately 16 to 20 weeks. A total of 60 adolescents will participate in the program, while a matched control group of 60 will be used for comparison. Key outcomes will include changes in Body Mass Index (BMI), eating disorder symptoms, functionality, and patient experiences assessed at discharge and after 6 and 12 months.
Why it matters
Potential benefit: If successful, this program could significantly improve recovery outcomes and quality of life for adolescents with eating disorders.
How similar studies have gone: While similar approaches have been explored, this specific program's comprehensive multi-phase treatment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for the prospective experimental group:
* Patient diagnosed with an Eating Disorder (according to the DSM-5) through a semi-structured interview (K-SADS PL-5)
* Aged between 12 and 17 years old
* Both patients and parents are willing to participate in the study and sign the informed consent to accept participation
* Patient with a poor response to treatment, defined as having one of the following two conditions:
1. undergoing over a year of treatment, including partial and total hospitalization, without symptom stabilization, experiencing severe psychological distress, eating symptomatology, comorbidities, or family dysfunction during this period (clinical improvement of at least 50 on the CGAS functioning scale) OR
2. undergoing more than three admissions without symptom stabilization (clinical improvement of at least 50 on the CGAS functioning scale).
Exclusion criteria for the prospective group:
* Acute ED pathology and biological decompensation that require urgent pediatric attention or admission to an acute psychiatric ward.
Inclusion criteria for the retrospective control group:
* Aged between 12 and 17 years old
* Diagnosed with an Eating Disorder (according to the DSM-5)
* Received treatment in Sant Joan de Déu between 2012 and 2022
* Patient with a poor response to treatment, defined as having one of the following two conditions:
1. undergoing over a year of treatment, including partial or total hospitalization, without achieving stabilization of ED symptomatology (needing high-intensive treatment units i.e. not being able to follow individual treatment in external consultations) OR
2. undergoing more than three admissions without symptom stabilization once referred to partial hospitalization in less than one year, including a similar psychological state and characteristics as the first condition
Exclusion criteria for the retrospective control group:
* Missingness of 20% or more of the required data
Where it's running
-
Hospital Sant Joan de Déu
Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Eduardo Serrano-Troncoso, Dr. — Hospital Sant Joan de Deu
- Study coordinator: Eduardo Serrano-Troncoso, Dr.
- Email: eserrano@sjdhospitalbarcelona.org
- Phone: 0034673837093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Eating Disorder Dynamic Intervention
A digital program is tested to help adults with eating disorders by sending real-time, personalized coping tips based on smartphone surveys and sensor data.
-
Long-term observation of severe eating disorders
This study is tracking adolescents and adults with severe eating disorders over many years to see what factors affect their health and recovery.
-
An AI chatbot to help teens and young adults with eating disorders manage anxiety about weight gain
This project will test an AI-powered chatbot that delivers exposure-based exercises to help adolescents and young adults in a partial hospitalization program reduce anxiety about weight gain.
-
Genetic study on eating disorders
This study is trying to understand the genetic and environmental causes of eating disorders by gathering information from 20,000 people with different eating disorders and healthy individuals.
-
Long-term study on eating disorders
This study is trying to understand eating disorders like Anorexia and Bulimia by looking at patients over time to find clues that could help improve treatments.
-
Cognitive evaluation for people with eating disorders
This project tests whether thinking skills (like cognitive flexibility and inhibitory control) and automatic food-related attitudes differ among people aged 14–65 with ARFID, anorexia, or bulimia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.